Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.580
-0.120 (-7.06%)
At close: Mar 28, 2025, 4:00 PM
1.616
+0.036 (2.27%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Longeveron Employees
Longeveron had 25 employees as of December 31, 2024. The number of employees increased by 1 or 4.17% compared to the previous year.
Employees
25
Change (1Y)
1
Growth (1Y)
4.17%
Revenue / Employee
$95,680
Profits / Employee
-$984,920
Market Cap
23.59M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LGVN News
- 19 days ago - Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease - GlobeNewsWire
- 25 days ago - Longeveron® to Present at the 37th Annual Roth Conference - GlobeNewsWire
- 4 weeks ago - Longeveron Inc. (LGVN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™ - GlobeNewsWire
- 3 months ago - Longeveron to Present at Biotech Showcase 2025 - GlobeNewsWire
- 4 months ago - Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024 - GlobeNewsWire
- 4 months ago - Longeveron, Inc. (LGVN) Q3 2024 Earnings Call Transcript - Seeking Alpha